BTG Pharmaceuticals

This July, we join the global community in recognizing Sarcoma and Bone Cancer Month and we renew our commitment to improving patient outcomes and raising awareness for these rare cancers. Last month, we had the honour of participating in the MIB Agents Osteosarcoma Alliance FACTOR Conference in Cleveland, a truly inspiring event that brought together leading osteosarcoma researchers, clinicians, patient families, osteosarcoma survivors, patients, and bereaved parents. The conference highlighted the importance of a collaborative approach to disease management, emphasizing the need for ongoing clinical trials and dedicated research to make significant strides in osteosarcoma treatment. The stories shared by patients and their families remind us of the urgency to accelerate our efforts to improve care in this critical area. The brave individuals and dedicated professionals we met at the FACTOR conference are top of mind as we observe Sarcoma and Bone Cancer Month. Let's amplify our commitment to osteosarcoma awareness and support this month. Together we can make a meaningful difference in the lives of those battling this disease. For more information: https://www.mibagents.org/ https://sarctrials.org/ #CureSarcoma #SarcomaAwareness #Osteosarcoma #Cancer #PatientCare 

We’re pleased to announce the appointment of Vanessa Wolfeler as the new CEO of SERB Pharmaceuticals. Vanessa is an accomplished leader with broad management experience, a track record of commercial successes, and expertise in scaling up organisations. She is a great fit for our strategy and culture. Read more: https://lnkd.in/gzVmNGPN #Leadership #WelcometotheTeam #ProudToSaveLives

We are always so proud to see our medicines protecting the brave men and women who dedicate their lives to the health and safety of the public. https://lnkd.in/e5ggyZBv #Firefighter #FirstResponder #EMS #ProudToSaveLives #IFFD2024

May is Oncology Nursing Month. Join us in celebrating the role oncology nurses play in patient care. Every day, around the world, these determined, dedicated, highly skilled professionals are on the front line in the battle with cancer – empowering hope and transforming care. Learn more about these extraordinary healthcare professionals: https://lnkd.in/e-3RkUgu #ThankANurse #NursesAreHeroes #OncologyNursingMonth #ONS24

Today SERB proudly announces our first Sustainability Report. In addition to delivering value to society through better health, we also recognise that our business has a responsibility to address the environmental, social, and governance (ESG) challenges of our time. This report describes our ESG activities and performance in 2023. Read our 2023 Sustainability Report here: https://lnkd.in/etZbQ-Wu

Our US Commercial Team gathered in Miami last week for our 2024 National Sales Meeting. The theme of this year’s meeting was Reinventing Today, Reimagining Tomorrow. Attendees discussed plans for the year ahead and gathered insights from physicians and hospital pharmacists who joined as invited guests. They also learned about the changing US healthcare market and how to make innovation happen from guest speaker Nadim Yacteen, Managing Partner at Recombinators | Inc. 5000 Company.   Teams also had the opportunity to show their competitive side in a hotly contested basketball shoot-out to benefit a charity of the winning team’s choice. The NSM is also our opportunity to recognise and celebrate achievements – congratulations to all of our Circle of Excellence and MVP award winners: Emergency Care CoE and MVP: J. Kevin Rogers Oncology CoE: John Mitchell Oncology MVP: Melanie M. Account Manager Award: Jamie Towey President's Award: Jami Johnson   #Reinvent #Reimagine #OneTeam

What a great week celebrating 2023 and focusing on how we can Reinvent and Reimagine our business and ways of working in 24! I’m also excited to share I won Circle of Excellence and MVP in 23. So thankful for a truly amazing group of professionals I get to work with every day! And in my 30+ years of being in this business, never have I attended a better NSM- at this company, they mean it when they talk about personal connections. Our US and global leaders know us all by name and seek out our ideas. This is a special company!

Our US Commercial Team gathered in Miami last week for our 2024 National Sales Meeting. The theme of this year’s meeting was Reinventing Today, Reimagining Tomorrow. Attendees discussed plans for the year ahead and gathered insights from physicians and hospital pharmacists who joined as invited guests. They also learned about the changing US healthcare market and how to make innovation happen from guest speaker Nadim Yacteen, Managing Partner at Recombinators | Inc. 5000 Company.   Teams also had the opportunity to show their competitive side in a hotly contested basketball shoot-out to benefit a charity of the winning team’s choice. The NSM is also our opportunity to recognise and celebrate achievements – congratulations to all of our Circle of Excellence and MVP award winners: Emergency Care CoE and MVP: J. Kevin Rogers Oncology CoE: John Mitchell Oncology MVP: Melanie M. Account Manager Award: Jamie Towey President's Award: Jami Johnson   #Reinvent #Reimagine #OneTeam

BTG will be exhibiting this week at the Hematology/Oncology Pharmacy Association (HOPA) 2024 conference. Come visit us in Booth #521 and learn more about the Voraxaze economic model and MTXPK.org updates at the Industry Encore Posters in Exhibit Hall beginning Wednesday April 3rd from 5-7pm (poster numbers 326 and 327). The posters remain on display until Friday, April 5 at 2pm.   #HOPA2024

BTG participated in Dress in Blue “BLUEsday” to bring awareness to colon cancer during National Colorectal Cancer Awareness Month. Colorectal cancer can be prevented, and it’s highly survivable when caught early. Screening can find colorectal cancer early, when treatment is most effective.   “Excluding skin cancers, colorectal cancer is the third most common cancer diagnosed in both men and women in the United States. The American Cancer Society’s estimates for the number of colorectal cancers in the United States for 2024 are: About 106,590 new cases of colon cancer (54,210 in men and 52,380 in women) About 46,220 new cases of rectal cancer (27,330 in men and 18,890 in women)” - The American Cancer Society #colorectalcancer #coloncancer #coloncancerawareness #GetScreeened https://lnkd.in/eRqCQ8yB